Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity

DOI 10.1016/j.immuni.2005.06.008

Cited by (1,004)

Items 401–500 of 1,004

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, Itishri, Haque, A.K.M. Ashiqul, Weidensee, Brian, Weinmann, Petra, Kormann, Michael S.D. · 2019 · Molecular Therapy
Modifications in Small Interfering RNA That Separate Immunostimulation from RNA Interference
Florian Eberle, Kerstin Gießler, Christopher Deck, Klaus M. Heeg, Mirjam E. Peter, Clemens Richert, Alexander H. Dalpke · 2008 · The Journal of Immunology
Role of Methylation in Pro- and Anti-Cancer Immunity
Ali Mehdi, Shafaat Ahmed Rabbani · 2021 · Cancers
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis
Wenbin Liao, Victor Pham, Linan Liu, Milad Riazifar, Egest James Pone, Shirley X. Zhang, Fengxia Ma, Mengrou Lu, Craig Michael Walsh, Weian Zhao · 2015 · Biomaterials
Chemical Modification Patterns Compatible with High Potency Dicer-Substrate Small Interfering RNAs
Michael A. Collingwood, Scott D. Rose, Lingyan Huang, Chris Hillier, M. Amarzguioui, Merete Thune Wiiger, Harris S. Soifer, John J. Rossi, Mark A. Behlke · 2008 · Oligonucleotides
miRNA and Methylation: A Multifaceted Liaison
Ravindresh Chhabra · 2014 · ChemBioChem
Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
David Alvarez-Carbonell, Yoelvis García‐Mesa, Stephanie Milne, Biswajit Das, Curtis N. Dobrowolski, Roxana E. Rojas, Jonathan Karn · 2017 · Retrovirology
Recent developments of RNA-based vaccines in cancer immunotherapy
Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Behzad Baradaran · 2020 · Expert Opinion on Biological Therapy
RNA Interference Technology
Wei Xu, Xuezhen Jiang, Linfeng Huang · 2019 · Elsevier eBooks
Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4
Amanda E Zelkoski, Zhongyan Lu, Gauthaman Sukumar, Clifton L. Dalgard, Hooda Said, Mohamad‐Gabriel Alameh, Edward E.S. Mitre, Allison M. W. Malloy · 2025 · npj Vaccines
Long-Read Sequencing – A Powerful Tool in Viral Transcriptome Research
Zsolt Boldogkői, Norbert Moldován, Zsolt Balázs, Michael P. Snyder, Dóra Tombácz · 2019 · Trends in Microbiology
The advent of clinical self-amplifying RNA vaccines
Irafasha C. Casmil, Jongwoo Jin, Eun-Jeong Won, Cynthia Huang, Suiyang Liao, Hyunjoo Cha‐Molstad, Anna K. Blakney · 2025 · Molecular Therapy
RNA Recognition via TLR7 and TLR8
Veit Hornung, Winfried Barchet, Martin Schlee, Gunther Hartmann · 2007 · Handbook of experimental pharmacology
Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
Cody D. Moorman, Sue J. Sohn, Hyewon Phee · 2021 · Frontiers in Immunology
Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
Siddharth Patel, Avathamsa Athirasala, Paula dos Passos Menezes, N. Ashwanikumar, Ting Zou, Gaurav Sahay, Luiz E. Bertassoni · 2018 · Tissue Engineering Part A
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed Akhtar Siddiqui, Imayavaramban Lakshmanan, Apar Kishor Ganti, Ravi Salgia, Maneesh Jain, Surinder K. Batra, Mohd Wasim Nasser · 2021 · Molecular Cancer
Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2
Rodolfo E. De la Vega, Martijn van Griensven, Wen Zhang, Michael J. Coenen, Christopher V. Nagelli, Joseph A. Panos, Carlos Julio Peniche Silva, Johannes P. Geiger, Christian Plank, Christopher H. Evans et al. · 2022 · Science Advances
Bacterial RNA: An Underestimated Stimulus for Innate Immune Responses
Tatjana Eigenbrod, Alexander H. Dalpke · 2015 · The Journal of Immunology
Type 2 Diabetes Mellitus: Limitations of Conventional Therapies and Intervention with Nucleic Acid-Based Therapeutics
Ganesh Rajendra Kokil, Rakesh Naduvile Veedu, Grant A. Ramm, Johannes B. Prins, Harendra S. Parekh · 2015 · Chemical Reviews
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
Jilian R. Melamed, Khalid A. Hajj, Namit Chaudhary, Daria Strelkova, Mariah Lynn Arral, Norbert Pardi, Mohamad‐Gabriel Alameh, Jason B. Miller, Lukas Farbiak, Daniel J. Siegwart et al. · 2021 · Journal of Controlled Release
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Kang, Diana D., Li, Haoyuan, Dong, Yizhou · 2023 · Advanced Drug Delivery Reviews
ADAR1: from basic mechanisms to inhibitors
Jan Rehwinkel, Parinaz Mehdipour · 2024 · Trends in Cell Biology
Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems
Julia A. Filippova, Anastasiya M. Matveeva, Evgenii S. Zhuravlev, Grigory A. Stepanov · 2019 · Biochimie
RNA-based pharmacotherapy for tumors: From bench to clinic and back
Xiangping Liang, Dongpei Li, Shuilong Leng, Xiao Ming Zhu · 2020 · Biomedicine & Pharmacotherapy
Messenger RNA-Based Vaccines Against Infectious Diseases
Alameh, Mohamad-Gabriel, Weissman, Drew, Pardi, Norbert · 2020 · Current Topics in Microbiology and Immunology
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
Navid Sobhani, Bruna Scaggiante, Rachel M. Morris, Dafei Chai, Martina Catalano, Dana Rae Tardiel-Cyril, Praveen Kumar Neeli, Giandomenico Roviello, Giuseppina Mondani, Yong Li · 2022 · Cancer Treatment Reviews
Recent trends in RNA informatics: a review of machine learning and deep learning for RNA secondary structure prediction and RNA drug discovery
Kengo Sato, Michiaki Hamada · 2023 · Briefings in Bioinformatics
The rise of epitranscriptomics: recent developments and future directions
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, Chuan He, Yanhong Shi · 2023 · Trends in Pharmacological Sciences
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
Phei Er Saw, Erwei Song · 2024 · Cell Reports Medicine
The ReNAissanCe of mRNA-based cancer therapy
Van Lint, Sandra, Renmans, Dries, Broos, Katrijn, Dewitte, Heleen, Lentacker, Ine, Heirman, Carlo, Breckpot, Karine, Thielemans, Kris · 2015 · Expert Review of Vaccines
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Conway, Anthony, Mendel, Matthew, Kim, Kenneth, McGovern, Kyle, Boyko, Alisa, Zhang, Lei, Miller, Jeffrey C., DeKelver, Russell C., Paschon, David E., Mui, Barbara L. et al. · 2019 · Molecular Therapy
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Albert Liu, Xiao Wang · 2022 · Frontiers in Cell and Developmental Biology
The advances of adjuvants in mRNA vaccines
Chunyuan Xie, Ruhui Yao, Xiaojun Xia · 2023 · npj Vaccines
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
Moyo, Nathifa, Vogel, Annette B., Buus, Søren, Erbar, Stephanie, Wee, Edmund G., Sahin, Ugur, Hanke, Tomáš · 2019 · Molecular Therapy - Methods & Clinical Development
Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy
Jiali Yang, Jiafeng Zhu, Jiaojiao Sun, Yiyun Chen, Yaran Du, Yiling Tan, Linpeng Wu, Mengting Zhai, Lixiang Wei, Na Li et al. · 2022 · Molecular Therapy — Nucleic Acids
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, Jun‐Hyeok Han, Ha Eun Shin, Se-Na Kim, Dooyong Jeong, Sang Hwi Lee, Bok-Hwan Chun, Chun Gwon Park et al. · 2023 · Nano Convergence
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Carmelo Biondo, Giacomo Signorino, Alessandro Costa, Angelina Midiri, Elisabetta Gerace, Roberta Galbo, Antonella Bellantoni, Antonio Malara, Concetta Beninati, Giuseppe Teti et al. · 2011 · European Journal of Immunology
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
Valentina Vavassori, Samuele Ferrari, Stefano Beretta, Claudia Asperti, Luisa Albano, Andrea Annoni, Chiara Gaddoni, Angelica Varesi, Monica Soldi, Alessandro Cuomo et al. · 2023 · Blood
Engineering nanoparticle toolkits for mRNA delivery
Bing Feng Sun, Weixi Wu, Eshan A. Narasipura, Yutian Ma, Chengzhong Yu, Owen S. Fenton, Hao Song · 2023 · Advanced Drug Delivery Reviews
Clinical translation of microbiome research
Jack A. Gilbert, Meghan B. Azad, Fredrik Bäckhed, Martin J. Blaser, Mariana Xavier Byndloss, Charles Y. Chiu, Hiutung Chu, Lara Ruth Dugas, Eran Elinav, Sean M. Gibbons et al. · 2025 · Nature Medicine
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering
Bramsen, Jesper B., Kjems, Jørgen · 2012 · Frontiers in Genetics
Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
Melissa L. Kelley, Žaklina Strezoska, Kaizhang He, Annaleen Vermeulen, Anja van Brabant Smith · 2016 · Journal of Biotechnology
Gene- and RNAi-activated scaffolds for bone tissue engineering: Current progress and future directions
Noah Z. Laird, Timothy M. Acri, Kelsie Tingle, Aliasger K. Salem · 2021 · Advanced Drug Delivery Reviews
Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins
Matthew Angel, Mehmet Fatih Yanik · 2010 · PLoS ONE
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord
Adee Heiman, Alexandra Pallottie, Robert F. Heary, Stella Elkabes · 2014 · Brain Behavior and Immunity
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Hojeong Shin, S.D. Park, Yeajee Yim, Jungho Kim, Chulwon Choi, Cheolhee Won, Dal‐Hee Min · 2018 · Advanced Therapeutics
mRNA-Based Genetic Reprogramming
Luigi A. Warren, Cory Lin · 2018 · Molecular Therapy
mRNA: A Novel Avenue to Antibody Therapy?
Thomas Schlake, Moritz Thran, Katja Fiedler, Regina Heidenreich, Benjamin Petsch, Mariola Fotin‐Mleczek · 2019 · Molecular Therapy
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O. Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura L. Sutherland, Richard M. Scearce, Maggie Barr, Amanda Eaton, Giovanna E. Hernandez et al. · 2021 · npj Vaccines
Photocaged 5′ cap analogues for optical control of mRNA translation in cells
Nils Klöcker, Florian P. Weissenboeck, Melissa van Dülmen, Petr Špaček, Sabine Hüwel, Andrea Rentmeister · 2022 · Nature Chemistry
Biomolecular condensates: new opportunities for drug discovery and RNA therapeutics
Brooke A. Conti, Mariano Oppikofer · 2022 · Trends in Pharmacological Sciences
Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich · 2024 · Nature Reviews Drug Discovery
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi · 2024 · Journal of Controlled Release
RNA chemistry and therapeutics
Siyu Wang, Drew Weissman, Yizhou Dong · 2025 · Nature Reviews Drug Discovery
Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines
Keith B. Gorden, Xiaohong Qiu, John L. Battiste, Paul D. Wightman, John P. Vasilakos, Şefik Ş. Alkan · 2006 · The Journal of Immunology
Extracellular RNA sensing by pattern recognition receptors
Tatematsu, Megumi, Funami, Kenji, Seya, Tsukasa, Matsumoto, Misako · 2018 · Journal of Innate Immunity
Biomaterials as vectors for the delivery of CRISPR–Cas9
Joon H. Eoh, Luo Gu · 2019 · Biomaterials Science
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
Anastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, Dmitry S. Kostyushev, Vladimir Chulanov · 2021 · Emerging Microbes & Infections
The epitranscriptome toolbox
Sharon Moshitch-Moshkovitz, Dan Dominissini, Gideon Rechavi · 2022 · Cell
The competitive landscape of the dsRNA world
Kyle A. Cottrell, Ryan J. Andrews, Brenda Bass · 2023 · Molecular Cell
Synthetic modified messenger RNA for therapeutic applications
Gao, Minsong, Zhang, Qingyi, Feng, Xin-Hua, Liu, Jianzhao · 2021 · Acta Biomaterialia
New Kids on the Block: RNA-Based Influenza Virus Vaccines
Francesco Berlanda Scorza, Norbert Pardi · 2018 · Vaccines
Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA
Satoshi Uchida, Kazunori Kataoka · 2019 · Journal of Biomedical Materials Research Part A
RNA Modification in the Immune System
Dali Han, Meng Michelle Xu · 2023 · Annual Review of Immunology
Pattern Recognition by Toll-like Receptors
Stefan Bauer, Thomas R Müller, Svetlana Hamm · 2009 · Advances in experimental medicine and biology
Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin
Golombek, Sonia, Pilz, Martin, Steinle, Heidrun, Kochba, Efrat, Levin, Yotam, Lunter, Dominique, Schlensak, Christian, Wendel, Hans Peter, Avci-Adali, Meltem · 2018 · Molecular Therapy Nucleic Acids
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency
McGee, Joshua E., Kirsch, Jack R., Kenney, Devin, Cerbo, Faith, Chavez, Elizabeth C., Shih, Ting-Yu, Douam, Florian, Wong, Wilson W., Grinstaff, Mark W. · 2025 · Nature Biotechnology
Trained immunity: Target for prophylaxis and therapy
Athanasios Ziogas, Mariolina Bruno, Roy van der Meel, Willem J. M. Mulder, Mihai Gheorghe Netea · 2023 · Cell Host & Microbe
Recent progress in mRNA cancer vaccines
Ruhui Yao, Chunyuan Xie, Xiaojun Xia · 2024 · Human Vaccines & Immunotherapeutics
Human TLR8 is activated upon recognition ofBorrelia burgdorferiRNA in the phagosome of human monocytes
Jorge Cervantes, Carson J. La Vake, Bennett Weinerman, Stephanie Luu, Caitlin M. O’Connell, Paulo H. Verardi, Juan Carlos Salazar · 2013 · Journal of Leukocyte Biology
Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
Satoshi Uchida, Kazunori Kataoka, Keiji Itaka · 2015 · Pharmaceutics
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Cailin E. Deal, Andrea Carfı́, Obadiah J. Plante · 2021 · Vaccines
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
Tutu Kalita, Saba Abbasi Dezfouli, Lalit Mohan Pandey, Hasan Uludağ · 2022 · Pharmaceutics
Gene Therapy for Regenerative Medicine
Hossein Hosseinkhani, Abraham Jacob Domb, Ghorbanali Sharifzadeh, Victoria Nahum · 2023 · Pharmaceutics
Tf-lipoplexes for neuronal siRNA delivery: A promising system to mediate gene silencing in the CNS
Ana Luísa Cardoso, Sérgio Simões, Luís Pereira de Almeida, Nikolaus Plesnila, Maria C. Pedroso de Lima, Ernst Wagner, Carsten Culmsee · 2008 · Journal of Controlled Release
Chemical Modification of siRNA
Glen F. Deleavey, Jonathan K. Watts, Masad José Damha · 2009 · Current Protocols in Nucleic Acid Chemistry
RNA modifications go viral
Nandan S. Gokhale, Stacy M. Horner · 2017 · PLoS Pathogens
An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, Emilie Bazin, Sylvie Commandeur, Vladimir Perkov, Katia Lemdani, Marie‐Claire Nicolaï, Patrick Bonifassi, Antoine Kichler et al. · 2022 · Biomaterials
BVDV: A pestivirus inducing tolerance of the innate immune response
Ernst Peterhans, Matthias Schweizer · 2012 · Biologicals
Uncovering the Role of RNA-Binding Proteins in Gene Expression in the Immune System
Manuel D. Díaz‐Muñoz, Martin Turner · 2018 · Frontiers in Immunology
Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS
Beverly, Michael, Dell, Amy, Parmar, Parul, Houghton, Leslie · 2016 · Analytical and Bioanalytical Chemistry
Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
Tyler E. Wagner, Jacob R. Becraft, Katie Bodner, Brian P. Teague, Xin Zhang, Amanda Rui En Woo, Ely B. Porter, Bremy Alburquerque, Brian S. Dobosh, Oliwia Andries et al. · 2018 · Nature Chemical Biology
Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells
Rein Verbeke, Ine Lentacker, Karine Breckpot, J. Janssens, Serge Van Calenbergh, Stefaan C. De Smedt, Heleen Dewitte · 2019 · ACS Nano
Amphiphilic Dendrimer Vectors for RNA Delivery: State-of-the-Art and Future Perspective
Jiaxuan Chen, Dandan Zhu, Xiaoxuan Liu, Ling Peng · 2022 · Accounts of Materials Research
Eliciting antitumor immunity via therapeutic cancer vaccines
Kun Peng, Xiaoxue Zhao, Yang‐Xin Fu, Yong Liang · 2025 · Cellular and Molecular Immunology
Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)
Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka, Marvin Sperling, Karen J. Klamerus, Katherine Chi-Burris, Eric Yan, Dario A. Paggiarino, Irit Rosenblatt, Roger Aitchison et al. · 2012 · Ophthalmology
siRNA delivery by a transferrin‐associated lipid‐based vector: a non‐viral strategy to mediate gene silencing
Ana Luísa Cardoso, Sérgio Simões, Luís Pereira de Almeida, Jaroslav Pelisek, Carsten Culmsee, Ernst Wagner, Maria C. Pedroso de Lima · 2007 · The Journal of Gene Medicine
Biomaterials in siRNA Delivery: A Comprehensive Review
William Ho, Xue‐Qing Zhang, Xiaoyang Xu · 2016 · Advanced Healthcare Materials
Role of Extracellular Damage-Associated Molecular Pattern Molecules (DAMPs) as Mediators of Persistent Pain
Jungo Kato, Camilla I. Svensson · 2015 · Progress in molecular biology and translational science
Emerging role of RNA modification N6-methyladenosine in immune evasion
Xin Lou, Juan-Juan Wang, Yaqing Wei, Jinjin Sun · 2021 · Cell Death and Disease
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
Hanwen Zhang, Xuexiang Han, Mohamad‐Gabriel Alameh, Sarah J. Shepherd, Marshall Scott Padilla, Lulu Xue, Kamila Butowska, Drew Weissman, Michael J. Mitchell · 2022 · Journal of Biomedical Materials Research Part A
Chimeric antigen receptor therapy meets mRNA technology
Jiacai Wu, Weigang Wu, Boping Zhou, Bin Li · 2023 · Trends in biotechnology
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan · 2024 · Advanced Drug Delivery Reviews
OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug
Shuvojit Banerjee, Elona Gusho, Christina Gaughan, Beihua Dong, Xiaorong Gu, Elise G. Holvey-Bates, Manisha Talukdar, Yize Li, Susan Reich Weiss, Frank Sicheri et al. · 2019 · Proceedings of the National Academy of Sciences
Endogenous Double-Stranded RNA
Shaymaa Sadeq, Surar Al-Hashimi, Carmen M. Cusack, Andreas Werner · 2021 · Non-Coding RNA
Potential roles of N6-methyladenosine (m6A) in immune cells
Chang Liu, Zhe Yang, Rong Li, Yanju Wu, Ming Chi, Shuting Gao, Xun Sun, Xin Meng, Biao Wang · 2021 · Journal of Translational Medicine
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
Zoltán Kis · 2022 · Pharmaceutics
Development of mRNA vaccines against respiratory syncytial virus (RSV)
Xirui Qiu, Siyan Xu, Yang Lu, Zichen Luo, Yang‐Tian Yan, Chuyue Wang, Jianjian Ji · 2022 · Cytokine & Growth Factor Reviews
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Kumar Singh, Pankaj Chandley, Soma Rohatgi · 2023 · ImmunoHorizons
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, Róbert Langer, Daniel G. Anderson · 2024 · Nature Reviews Drug Discovery